Disclaimer. This site reads publicly available research papers and corporate filings and explains what they say. It is not investment advice and does not recommend buying or selling any security. Historical cases shown here are computed from public data; the sample sizes are small and are not a basis for prediction. We do not answer questions about individual stocks.
Readouts · Company page
Jiangsu Hengrui
Company facts
- Status
- SSE 600276
- Links
- Quote · 东方财富
Financial summary (from filings)
Not shown: this market has no free public API for financial statements (Korea's DART, the U.S. SEC and Japan's EDINET do). See the filings link for the originals.
Readouts that mention this company
National R&D projects (NTIS)
No records
Korean patent filings (KIPRIS)
국내 출원인 표기 없음
Papers with affiliated authors (OpenAlex)
219
item
Papers by year
| 2025 |
|---|
| 219 |
Companies in the same readouts
- Dong-A ST
- Chugai Pharmaceutical
- Eli Lilly
- Hangzhou Zhongmei Huadong
- Eccogene
- Novo Nordisk
- Hanmi Pharmaceutical
- LG H&H
Last updated 2026-09-21